Zogenix Inc (NASDAQ:ZGNX) Could Burn Your Long Portfolio After More Shorts

June 16, 2018 - By Kurt Siggers

Zogenix, Inc. (NASDAQ:ZGNX) Logo

The stock of Zogenix Inc (NASDAQ:ZGNX) registered an increase of 1.5% in short interest. ZGNX’s total short interest was 4.37M shares in June as published by FINRA. Its up 1.5% from 4.31M shares, reported previously. With 461,100 shares average volume, it will take short sellers 10 days to cover their ZGNX’s short positions. The short interest to Zogenix Inc’s float is 15.63%.

The stock increased 0.45% or $0.2 during the last trading session, reaching $45. About 405,630 shares traded. Zogenix, Inc. (NASDAQ:ZGNX) has risen 225.58% since June 16, 2017 and is uptrending. It has outperformed by 213.01% the S&P500.

Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders in the United States. The company has market cap of $1.59 billion. The companyÂ’s lead product candidate is the ZX008, a low-dose fenfluramine, which is in Phase III clinical trials for the treatment of seizures associated with Dravet syndrome. It currently has negative earnings. It also develops Relday, an injectable formulation of risperidone to treat the symptoms of schizophrenia and bipolar disorder in adults and teenagers with 13 years of age and older.

Another recent and important Zogenix, Inc. (NASDAQ:ZGNX) news was published by Seekingalpha.com which published an article titled: “Reader Inquiry: Is There Further Upside In Zogenix?” on May 26, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: